Skip to main content
logo
Genmab A/S (LON:0MGB)
London flag London · Delayed Price · Currency is GBP · Price in DKK
1,857.70
+12.22 (0.66%)
At close: Oct 31, 2025

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 20212011 - 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 2011 - 2020
Denmark Revenue
-2.75B
Log In
Log In
Log In
Upgrade
United States Revenue
-125.29M
Log In
Log In
Log In
Upgrade
Japan Revenue
-116.82M
Log In
Log In
Log In
Upgrade

Revenue Breakdown

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 20212011 - 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 2011 - 2020
DARZALEX Royalties Revenue
2.17B1.93B
Log In
Log In
Log In
Upgrade
Kesimpta Royalties Revenue
369.13M308.65M
Log In
Log In
Log In
Upgrade
TEPEZZA Royalties Revenue
99.87M102.37M
Log In
Log In
Log In
Upgrade
Other Product Royalties Revenue
80.75M65.42M
Log In
Log In
Log In
Upgrade
Total Royalties Revenue
2.72B2.41B
Log In
Log In
Log In
Upgrade
Reimbursement Revenue
95.31M138.35M
Log In
Log In
Log In
Upgrade
Milestone Revenue
104.26M138.90M
Log In
Log In
Log In
Upgrade
Collaboration Revenue
68.53M60.15M
Log In
Log In
Log In
Upgrade
License Revenue
-277.81K
Log In
Log In
Log In
Upgrade
Net Product Sales
313.38M242.11M
Log In
Log In
Log In
Upgrade

Revenue Breakdown 2

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 20212011 - 2020
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22 Dec '21 2011 - 2020
J&J Revenue
2.26B2.00B
Log In
Log In
Log In
Upgrade
Roche Revenue
101.42M102.93M
Log In
Log In
Log In
Upgrade
Novartis Revenue
453.22M391.99M
Log In
Log In
Log In
Upgrade
BioNTech Revenue
80.01M120.71M
Log In
Log In
Log In
Upgrade
Pfizer Revenue
79.48M74.04M
Log In
Log In
Log In
Upgrade
AbbVie Revenue
12.44M54.73M
Log In
Log In
Log In
Upgrade
Other Collaboration Partner Revenue
2.28M277.81K
Log In
Log In
Log In
Upgrade
Updated Jun 30, 2025. Data Source: Fiscal.ai.